BioSpace News Archive

SunRock Biopharma S.L. announce that they have entered into an exclusive licensing agreement for SRB22, a fully human bifunctional HER3:TRAIL fusion protein, which going forward will be known as EP0017.

Vizient Group Senior Vice President, Pharmacy Solutions Dan Kistner will present at the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Quality Management Maturity (QMM) Workshop , which is being held May 24-25, 2022.

TARGAN (formerly Applied LifeSciences & Systems (ALSS)) announced today it has secured $35 million of Series C equity financing.

Seegene Inc. (KQ096530), South Korea’s leading molecular diagnostics (MDx) company, today unveiled a global initiative for preemptive and routine PCR testing to help individuals stay safe and healthy while living in the COVID-19 era.

GENFIT, a late-stage biopharmaceutical company dedicated to improving the lives of patients with severe chronic liver diseases, announced the results of the Combined Shareholders Meeting which took place on May 25, 2022.

Bruker Corporation (Nasdaq: BRKR) announced today it will present at the Jefferies 2022 Global Healthcare Conference in New York on Thursday, June 9, 2022 at 3:00 pm EDT.

Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced that members of the management team will participate in the upcoming 19th Annual Craig-Hallum Institutional Investor Conference on June 1st, 2022.

Hyundai Bioscience will go straight to the US with its broad-spectrum antiviral drug candidate to treat monkeypox.

Hyperfine (Nasdaq: HYPR), the creator of Swoop®, the world’s first FDA-cleared portable MRI system™, today announced that management will be presenting at the upcoming 2022 Jefferies Global Healthcare Conference in New York, New York.

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that it will be participating in the 19th Annual Craig-Hallum Institutional Investor Conference being held virtually on Wednesday, June 1, 2022.